Incidence, survival, and symptoms at recurrence among vulvar cancer patients treated with curative intent: a population-based cohort study

医学 队列研究 外阴癌 内科学 队列 肿瘤科 回顾性队列研究 癌症 梅德林 妇科 外科 外阴
作者
Louise Krog,Tine Henrichsen Schnack,Ligita Paskeviciute Frøding,Katrine Fuglsang,Peter Christensen,Liselotte Due,Mogens Grøenvold,Lars Dyrskjøt,Pernille Tine Jensen
出处
期刊:American Journal of Obstetrics and Gynecology [Elsevier BV]
标识
DOI:10.1016/j.ajog.2026.08.047
摘要

BACKGROUND: Vulvar cancer is a rare and mutilating disease with a high recurrence rate. Prior studies have reported relatively favorable survival rates after primary disease, while survival after recurrence is poor. Yet there is limited knowledge on recurrence and survival patterns following primary diagnosis, first, and second recurrence. Although many recurrences are local, their detection may be challenged by limitations in self-examination and inadequate knowledge of symptoms. Consequently, further knowledge of symptoms preceding a vulvar cancer recurrence may improve understanding of early manifestations to inform patient education and support early detection and treatment of recurrent disease. OBJECTIVE: In this study, we aimed to describe recurrence incidences for first, second, and third recurrence, estimate overall survival following primary diagnosis, first, and second recurrence, and identify symptoms preceding first recurrence. STUDY DESIGN: We conducted a population-based nationwide cohort study in Denmark. All patients with primary vulvar squamous cell carcinoma who were prospectively registered in the Danish Gynecological Cancer Database during 2011 to 2022 and who underwent curatively intended treatment were included. Data were validated and enriched with data from hospital charts. The cumulative incidences of first, second, and third recurrence were estimated using the Aalen-Johansen estimator, accounting for death before recurrence as a competing event. Overall survival was estimated by the Kaplan-Meier method. Symptom analyses were descriptive and included symptom frequencies stratified by recurrence location and visual exploration of symptom co-occurrence using selected 2×2 tables and bar-chart summaries. RESULTS: We identified 800 patients with a median follow-up of 68.8 months (interquartile range 39.7-104.9). The cumulative incidence of first recurrence was 19.2% (95% confidence interval, 16.6-22.1) at 24 months and 35.0% (95% confidence interval 31.3-38.8) at 120 months. The 5-year overall survival following primary diagnosis was 73.3% (95% confidence interval, 69.9-76.3), decreasing to 38.2% (95% confidence interval, 31.5-44.9) following the first recurrence, though only to 49.8% (95% confidence interval, 40.1-58.7) following the first isolated local recurrence. More than half of the patients with a recurrence had an isolated local recurrence (n=149, 58.9%), one fourth had a distant recurrence (n=60, 23.7%), and only a few had either a locoregional (n=17, 6.7%) or an isolated regional recurrence (n=22, 8.7%). Median time from completion of primary treatment to local, locoregional, regional, or distant recurrence was 24.5 (interquartile range , 10.5-43.7), 7.0 (interquartile range, 3.9-23.7), 8.1 (interquartile range, 4.9-13.3), and 9.0 (interquartile range, 4.8-19.4) months, respectively. Nearly all patients with a local, locoregional, or regional recurrence experienced at least one out of several predefined symptoms preceding the first recurrence (n=213, 94.7%). The symptoms varied according to recurrence location. Itching often appeared alongside vulvar pain in local recurrences, while groin tumors frequently appeared with groin pain in regional recurrences. CONCLUSION: Vulvar cancer recurrences were common, with isolated local recurrences occurring at a relatively constant rate for up to 9 years posttreatment. Overall survival after primary diagnosis was favorable but decreased markedly following first and second recurrence. Most recurrences were preceded by predefined symptoms, highlighting the importance of symptom awareness.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
研友_VZG7GZ的应助被科研通管家采纳,获得10
刚刚
天天快乐的应助被zww采纳,获得10
刚刚
刚刚
852的应助被WD采纳,获得10
1秒前
Frank发布了新的文献求助10
1秒前
1秒前
Hello的应助被LSQ47采纳,获得10
2秒前
3秒前
云山约完成签到 ,获得积分10
5秒前
6秒前
科研通AI6.2的应助被xushengyang采纳,获得10
7秒前
7秒前
7秒前
8秒前
丫丫完成签到,获得积分10
8秒前
研友_kngjrL发布了新的文献求助100
9秒前
10秒前
10秒前
凹凸曼发布了新的文献求助10
10秒前
秋风的应助被imneko采纳,获得10
10秒前
勤恳镜子发布了新的文献求助10
10秒前
11秒前
12秒前
乱序完成签到,获得积分10
12秒前
13秒前
丁驰发布了新的文献求助10
13秒前
15秒前
Lwssss发布了新的文献求助10
15秒前
1001发布了新的文献求助10
16秒前
abcd完成签到 ,获得积分10
16秒前
17秒前
Agoni发布了新的文献求助10
17秒前
17秒前
18秒前
18秒前
喵不吃鱼发布了新的文献求助10
19秒前
斤斤计较完成签到,获得积分20
19秒前
GIN的应助被noliey采纳,获得30
20秒前
1liuxiaog发布了新的文献求助10
21秒前
伤心猪大肠完成签到,获得积分10
21秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Handbook of Sport Coaching Research 1000
Orthognathic Surgery - 2 Volume Set 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8192871
求助须知:如何正确求助?哪些是违规求助? 9579281
关于积分的说明 21864358
捐赠科研通 7792445
什么是DOI,文献DOI怎么找? 3437059
关于科研通互助平台的介绍 2560639
邀请新用户注册赠送积分活动 2483928